Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022
Persistence Market Research
Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022
Persistence Market Research
1
Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022 Persistence Market Research Released New Market Report on “Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022”. Hypocalcaemia is imbalance of electrolytes which is indicated by abnormally low level of calcium in the body. A healthy person has 8.5-10.2 mg/dL calcium level in his/her body, however, drop in this level could possibly led to hypocalcaemia disorder. Middle aged population needs to take 1000 mg of calcium while geriatrics population aged 65 and above should take 1500 mg of calcium per day. Hypocalcaemia is caused by hypoalbuminemia, hyperphosphatemia, surgical effects, medication effects, hypomagnesemia, heart failure, muscle cramps, vitamin D deficiency, alcoholism, magnesium deficiency, insufficient protein in the blood, in the blood and many more. Neuromuscular irritability is the most common sign of hypocalcaemia. Hypocalcaemia are mostly diagnosed by clinical suspicion and laboratory testing. Hypoparathyroidism has a major effect on hypocalcaemia and high recurrence rate. The hypocalcaemia can be caused at any age but it is commonly observed in ill patients and patients with parathyroid surgery and with increase in the prevalence of heat related disorders in the older population witnessing the growth of hypocalcaemia treatment market is expected to expand at considerable CAGR during the forecasted period. Also, with increase in the awareness among the aging population and availability of treatment creates an opportunity for hypocalcaemia treatment market worldwide. However, the biochemical abnormality associated with hypocalcaemia carries risks in diagnosis and treatment. Interested in report: Please follow the below the links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/9650 The Hypocalcaemia Treatment Market has been classified on the basis of product, application, end use and geography. Hypocalcaemia Treatment Market by type: •
Asymptomatic
•
Symptomatic
•
Prophylactic
Hypocalcaemia Treatment Market by Drug type: •
Radiocontrast
•
Loop diuretics
Persistence Market Research
2
Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022 •
Calcium supplements
•
Antibiotics
•
Antiepileptic drugs
•
Estrogen
•
Bisphosphonates
•
Cinacalcet
Hypocalcaemia Treatment Market by dosage forms type: Calcium supplements •
Parenteral preparation
•
Oral preparation
Vitamin D supplements •
Parenteral preparation
•
Oral preparation
Parenteral calcium supplements dosage are given to patients suffering from acute hypocalcaemia. Whereas, in case of chronic hypocalcaemia oral calcium supplements are administered. Medical supervision is given to avoid risk associated with parenteral administration. With increasing demand for effective treatment of hypocalcemia, companies need to capitalize on their resources to offer effective medications and in turn further expand their business footprint in developing regions. Request TOC (table of content), Figures http://www.persistencemarketresearch.com/toc/9650
and
Tables
of
the
Report:
Depending on geographic region, hypocalcaemia treatment market is segmented into seven key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Incidence rate of hypocalcaemia is quite high in North America compared to other regions. North America dominates the global hypocalcaemia treatment market followed by Europe, Asia Pacific owing to high awareness about the treatments of hypocalcaemia in these regions. The developing regions such as Asia Pacific, Middle East & Africa hold huge potential and is a promising market for hypocalcaemia treatment due to significant increase in medical tourism industry. Key players of Hypocalcaemia Treatment Market are F. Hoffman La Roche, Novo Nordisk, Sanofi, GlaxoSmithKline (GSK), Pfizer Inc., and Ranbaxy Pharmaceuticals Ltd.
Persistence Market Research
3
Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022
For more Info: http://www.persistencemarketresearch.com/contact-us.asp The report covers exhaustive analysis on: •
Hypocalcaemia Treatment Market Segments
•
Hypocalcaemia Treatment Market Dynamics
•
Historical Actual Market Size, 2013 - 2015
•
Hypocalcaemia Treatment Market Size & Forecast 2016 to 2022
•
Hypocalcaemia Treatment Market Current Trends/Issues/Challenges
•
Competition & Companies involved
•
Hypocalcaemia Treatment Market Drivers and Restraints
Regional analysis includes •
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East and Africa
Report Highlights: •
Shifting Industry dynamics
•
In-depth market segmentation
•
Historical, current and projected industry size
•
Recent industry trends
•
Key Competition landscape
•
Strategies of key players and product offerings
•
Potential and niche segments/regions exhibiting promising growth
•
A neutral perspective towards market performance
Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2. The report covers geographic segmentation
Persistence Market Research
4
Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022 3.
North America Europe Asia RoW The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4. The report provides company profiles of some of the leading companies operating in the market 5. The report also provides porters five forces analysis of the market. Browse the full “All Upcoming Persistence Market's ” report at http://www.persistencemarketresearch.com/forthcoming-reports.asp About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services At Persistence Market Research (PMR), we are in the business of accelerating your business. As a full-service market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability. PMR’s Services Go Beyond Gleaning Data: Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by carefully balancing traditional and modern-day research methodologies. Contact Us: Addie Thomes 305 Broadway, 7th Floor, Persistence Market Research
5
Hypocalcaemia Treatment Market: Global Industry Analysis and Forecast 2016 – 2022 New York City, NY 10007, United States. Phone: +1-646-568-7751 USA/Canada Toll Free Number. 1-800-961-0353 E-mail: Sales@persistencemarketresearch.com Web : http://www.persistencemarketresearch.com/
Persistence Market Research
6